Comparative study between intraarticular ostenil versus orthovisc

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN43185756

Enrollment

146

Registered

2005-09-30

Start date

2004-05-01

Completion date

Unknown

Last updated

2017-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases: Osteoarthritis of the knee Musculoskeletal Diseases Osteoarthritis of the knee

Interventions

Intraarticular ostenil versus orthovisc

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Male and female 2. Diagnosed with osteoarthritis of the knee

Exclusion criteria

Exclusion criteria: 1. Other known inflammatory arthropathies eg psoriasis, sero-negative arthropathies 2. Grade 4 osteoarthritis on the Kellgren score 3. Previous intra articular injections (except previous steroids or local anaesthetic) 4. Laxity or deformity 5. Uncontrolled diabetes, pregnancy, major existing medical problems, liver and renal diseases 6. Immunosuppressed and those on high dose steroids for any reason 7. Local infection at site and patients with gross pedal oedema 8. Patients with hypersensitivity to hyaluronic acid 9. Patients unwilling to participate or unable to give consent

Design outcomes

Primary

Measure	Time frame
1. WOMAC - Western Ontario and McMaster Universities Arthritis Index 2. VAS - pain scale	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026